Covered recipient · General Payments record
MANUSHI AGGARWAL
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,206.91
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.24 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.32 | 8 |
| Janssen Biotech, Inc. | $56.99 | 2 |
| Acerta Pharma LLC | $29.40 | 1 |
| Organon LLC | $15.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.76 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180102 | CMS |
| ABBVIE INC. | $2.16 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180104 | CMS |
| ABBVIE INC. | $2.38 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180106 | CMS |
| ABBVIE INC. | $1.25 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180108 | CMS |
| ABBVIE INC. | $4.70 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180110 | CMS |
| ABBVIE INC. | $116.59 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180112 | CMS |
| ABBVIE INC. | $3.50 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180114 | CMS |
| ABBVIE INC. | $1.98 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103180116 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.40 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104491982 | CMS |
| Janssen Biotech, Inc. | $28.44 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078562742 | CMS |
| Janssen Biotech, Inc. | $28.55 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078563955 | CMS |
| Organon Llc | $15.53 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136291105 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.